Avertissement: Ce site agrège des données publiques officielles provenant de la FDA, ClinicalTrials.gov, PubMed et SEC EDGAR à titre de référence générale uniquement. Il ne constitue pas un avis médical, un diagnostic, une recommandation de traitement ni un conseil en investissement.

Essai clinique

Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction

NCT : NCT07771660 · COMPLETED

ID NCTNCT07771660
StatutCOMPLETED
Date de début2024-05-25
Achèvement2025-12-09
SponsorAnkara University (OTHER)
First posted
Last updated

Résumé succinct

This single-center, parallel-group randomized clinical trial compared 2 orthopedic treatment approaches in growing patients with skeletal Class III malocclusion associated predominantly with maxillary deficiency: the Ertty Gap III appliance and facemask therapy. Forty-two participants were randomly allocated in a 1:1 ratio to Ertty Gap III or facemask therapy. The primary objective was to compare the short-term skeletal effects of the 2 treatment protocols, with the ANB angle designated as the primary outcome. Skeletal, dentoalveolar, and soft-tissue outcomes were assessed using standardized lateral cephalometric radiographs obtained before treatment and at treatment completion.

Source officielle

Voir sur ClinicalTrials.gov →

Données issues de l’API ClinicalTrials.gov. Pour connaître le statut le plus récent, consultez la fiche officielle.

↑